Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast in Allergic Asthma
NCT01365533Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2004
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of roflumilast in allergic asthma, sponsored by AstraZeneca. Started Dec 2004; status: completed.
02
Drugs
roflumilast
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT01365533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01365533.